Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of Mycobacterium tuberculosis –Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection

The Journal of Immunology(2022)10.4049/jimmunol.2200140Source: DataRank Database

Characterization of Mycobacterium tuberculosis –Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection is a research paper published in The Journal of Immunology (2022). On theSindex it has a DataRank of 0.312. It has been cited 7 times.

N/A

0.312DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)OA: hybridTopics (32)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.312

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (6)

Millicent A. Omondi ORCID,Rubina Bunjun ORCID,Robert J. Wilkinson ORCID,Catherine Riou ORCID,Wendy A. Burgers ORCID

Live enrichment

PubMed:35777848 PMC:PMC9339498

EC | H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership

Grant: TMA2016SF-1535-CaTCH-22

EC | H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership

Grant: TMA2017SF-1951-TB-Spec

South African Medical Research Council

Grant: 92755

National Health Laboratory Service

Grant: 2016-2DEV04

HHS | NIH | NIH Office of the Director

Grant: R21AI115977

Wellcome Trust

Grant: 203135

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)

Wellcome Trust

Grant: 104803

HHS | National Institutes of Health

Grant: U01 AI115940

Francis Crick Institute

Grant: FC0010218

The Francis Crick Institute

Grant: 10218

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2017SF-1951

The Francis Crick Institute

Grant: CC2112

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2016SF-1535

Wellcome Trust

Grant: 104803/Z/14/Z

National Institutes of Health

Grant: 1R21AI115977-01

Diversity of CD4+ Th subsets in TB immunity - Impact of HIV infection

National Institutes of Health

Grant: 5U01AI115940-04

Inflammatory determinants of disease severity and treatment outcome in TB patients

Wellcome Trust

hybridLicense: cc-by

publisherhttps://journals.aai.org/jimmunol/article-pdf/209/3/446/1487334/ji2200140.pdf

publisherhttps://academic.oup.com/jimmunol/article-pdf/209/3/446/61467095/ji2200140.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9339498

https://doi.org/10.1101/2020.10.22.20217521

https://www.medrxiv.org/content/medrxiv/early/2020/10/26/2020.10.22.20217521.1.full.pdf

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences0302 clinical medicine

MeSH Terms

CD4-Positive T-LymphocytesT-Lymphocytes, Helper-InducerTh1 CellsHumansMycobacterium tuberculosisTuberculosisHIV InfectionsInterleukin-17Latent TuberculosisTh17 CellsCoinfection

Keywords

CD4-Positive T-LymphocytesModel organismsHuman Biology & PhysiologyCoinfectionFOS: Clinical medicineInterleukin-17ImmunologyHIV InfectionsInfectious DiseaseMycobacterium tuberculosisT-Lymphocytes, Helper-InducerTh1 CellsLatent TuberculosisHumansTh17 CellsTuberculosisClinical and Human Immunology

Sustainable Development Goals

SDG 3: 3. Good health